Publications by authors named "Emilia Anderson"
Expert Opin Biol Ther
November 2023
Article Synopsis
- Biosimilar adalimumabs have made treatment more accessible but lack clinical advantages, leading distributors to highlight design improvements and support services instead.*
-
- A thorough comparison between the original adalimumab (Humira) and four biosimilars revealed key differences in formulation, dosages, delivery devices, and support services.*
-
- Choosing between adalimumab options should be personalized based on distinct advantages and disadvantages of each product, tailored to patient and healthcare provider needs.*
